Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)

NCT ID: NCT01100684

Last Updated: 2013-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

611 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-05-31

Study Completion Date

2013-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether asimadoline is safe and effective at treating D-IBS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of the study is to compare the efficacy of the two treatments with respect to improvement in IBS-related abdominal pain severity and reduction in stool frequency. During the 12-week treatment period, daily IBS-related abdominal pain severity score and daily frequency of bowel movements will be averaged over each week to determine average values for each endpoint. For each subject, weekly response to treatment will be based on the following parameters:

* Decrease from baseline of at least 30% in the average IBS-related daily abdominal pain severity score
* Decrease from baseline of at least 25% in the average number of daily bowel movements A subject must meet both criteria to be considered a weekly responder. The primary efficacy endpoint is based on an "overall study responder," defined as a subject having 6 or more weeks of weekly response to treatment out of the 12 weeks in the treatment period. Overall study responder will be stratified by timing of bowel preparation and endoscopy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diarrhea Predominant Irritable Bowel Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

diarrhea predominant irritable bowel syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment

0.5 mg asimadoline bid

Group Type EXPERIMENTAL

Asimadoline

Intervention Type DRUG

0.5 mg Asimadoline BID

Placebo

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Asimadoline

0.5 mg Asimadoline BID

Intervention Type DRUG

Placebo

Placebo

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

EMD 61 753 EMR 63 320

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Signs and dates a written informed consent form.
2. Male and female subjects aged 18-79 who are fluent in English
3. All subjects must use protocol specified contraceptive measures
4. The subject is or has been diagnosed with IBS with symptom onset at least 6 months prior to diagnosis. IBS is defined as the subject having recurrent abdominal pain or discomfort at least 3 days per month in the past 3 months associated with at least two of the following symptoms:

Improvement with defecation Onset associated with a change in frequency of stool Onset associated with a change in form (appearance) of stool
5. The subject has been diagnosed with diarrhea-predominant IBS
6. Within 2 years of the randomization visit, the subject has normal results from a flexible sigmoidoscopy, a colonoscopy, or a barium enema plus flexible sigmoidoscopy, according to the subject's age by a specified algorithm.

Exclusion Criteria

1. The subject exhibits evidence of a biochemical or structural abnormality of the digestive tract.
2. Subject has a concurrent illness or disability (excluding IBS) that may affect the interpretation of clinical efficacy and/or safety data or otherwise contraindicates participation in this clinical study (e.g., an unstable cardiovascular, renal, hepatic, pulmonary, endocrine, metabolic, GI, hematological, or neurological condition).
3. The subject has a family history of prolonged QT syndrome.
4. The subject has been diagnosed with a major psychiatric disorder.
5. The subject has a history of alcohol or substance abuse within the past 2 years.
6. The subject has a history or current evidence of laxative abuse
7. The subject has a positive stool sample for ova or parasite.
8. The subject has used an investigational drug or participated in an investigational study within 30 days of screening.
9. The subject refuses to discontinue one (or more) prohibited medications at least 7 days prior to the screening visit.
10. The subject refuses to maintain a stable dose of one (or more) allowable concurrent medications for at least 30 days prior to the screening visit.
11. The subject is a pregnant woman or a woman who is breast feeding.
12. The subject is unable or unwilling to follow directions or use the electronic diary system.
Minimum Eligible Age

18 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

RTI Health Solutions

OTHER

Sponsor Role collaborator

Tioga Pharmaceuticals

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Allen Mangel, M.D.Ph.D.

Role: STUDY_CHAIR

CMO

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

North Alabama Research Center, LLC

Athens, Alabama, United States

Site Status

Alliance Clinical Research

Birmingham, Alabama, United States

Site Status

Medical Affliated Research Center, Inc.

Huntsville, Alabama, United States

Site Status

Saadat Ansari MD LLC

Huntsville, Alabama, United States

Site Status

Connect Clinical Research Center

Chandler, Arizona, United States

Site Status

Digestive Health Research Unit

Scottsdale, Arizona, United States

Site Status

Adobe Clinical Research, LLC

Tucson, Arizona, United States

Site Status

ACRC/Arizona Clinical Research Center, Inc.

Tucson, Arizona, United States

Site Status

Genova Clinical Research

Tucson, Arizona, United States

Site Status

W/C Clinical Research

Tucson, Arizona, United States

Site Status

Lynn Institute of the Ozarks

Little Rock, Arkansas, United States

Site Status

Applied Research Center of Arkansas

Little Rock, Arkansas, United States

Site Status

Arkansas Gastroenterology

Sherwood, Arkansas, United States

Site Status

Providence Clinical Research

Burbank, California, United States

Site Status

GW Research Inc,

Chula Vista, California, United States

Site Status

La Jolla Clinical Research, Inc

Chula Vista, California, United States

Site Status

Discovery Clinical Research

Encinitas, California, United States

Site Status

Digestive & Liver Disease Specialist

Garden Grove, California, United States

Site Status

Collaborative Neuroscience Network Inc

Long Beach, California, United States

Site Status

California Gastroenterology Associates

Madera, California, United States

Site Status

Community Clinical Trials

Orange, California, United States

Site Status

Sutter Medical Group Gastroenterology

Sacramento, California, United States

Site Status

Medical Center for Clinical Research

San Diego, California, United States

Site Status

Medical Associates Research Group, Inc.

San Diego, California, United States

Site Status

Westlake Medical Research

Westlake Village, California, United States

Site Status

Lynne Institute of the Rockies

Colorado Springs, Colorado, United States

Site Status

Arapahoe Gastroenterology

Littleton, Colorado, United States

Site Status

Lynn Institute of Pueblo

Pueblo, Colorado, United States

Site Status

Rocky Mountain Gastroenterology Associates

Thornton, Colorado, United States

Site Status

Danbury Clinical Research, LLC

Danbury, Connecticut, United States

Site Status

Chase Medical Research, LLC

Waterbury, Connecticut, United States

Site Status

Consultants for Clinical Research of South Florida

Boynton Beach, Florida, United States

Site Status

Meridien Research

Brookville, Florida, United States

Site Status

BioPharma Research

Coral Gables, Florida, United States

Site Status

Riverside Clinical Research

Edgewater, Florida, United States

Site Status

A.G.A. Clinical Trials

Hialeah, Florida, United States

Site Status

Altus Research

Lake Worth, Florida, United States

Site Status

Center for Advanced Gastroenterology

Maitland, Florida, United States

Site Status

FIRC

Miami, Florida, United States

Site Status

DMI Research

Pinellas Park, Florida, United States

Site Status

Accord Clinical Research, LLC

Port Orange, Florida, United States

Site Status

International Clinical Research-US,LLC

Sanford, Florida, United States

Site Status

Lakeview Medical Research

Summerfield, Florida, United States

Site Status

Venra Clinical Studies, LLC

Wellington, Florida, United States

Site Status

Alliance Clinical Research

Winter Park, Florida, United States

Site Status

Atlanta Center for Gastroenterology

Decatur, Georgia, United States

Site Status

Tri County Research

Hartwell, Georgia, United States

Site Status

Northwest Gastroenterologist S.C.

Arlington Heights, Illinois, United States

Site Status

Illinois Center for Clinical Research

Chicago, Illinois, United States

Site Status

Southwest Gastroenterology

Oak Lawn, Illinois, United States

Site Status

Elkhart Clinic, LLC/Indiana Medical Research, LLC

Elkhart, Indiana, United States

Site Status

MediSphere Medical Research Center, LLC

Evansville, Indiana, United States

Site Status

Mercy Gastroenterology Clinic

Clive, Iowa, United States

Site Status

Gastrointestinal Clinic of Quad Cities

Davenport, Iowa, United States

Site Status

Heartland Research Associates, LLC

Newton, Kansas, United States

Site Status

Heartland Research Associates, LLC

Wichita, Kansas, United States

Site Status

Graves-Gilbert Clinic

Bowling Green, Kentucky, United States

Site Status

Tri-State Gastroenterology Associates, PSC

Crestview Hills, Kentucky, United States

Site Status

Hometown Urgent Care and Research

Hebron, Kentucky, United States

Site Status

The Research Group of Lexington, LLC

Lexington, Kentucky, United States

Site Status

University of Louisville Medical-Dental Complex

Louisville, Kentucky, United States

Site Status

Tover Health Systems Center for Clinical Research

Madisonville, Kentucky, United States

Site Status

Investigative Clinical Research

Annapolis, Maryland, United States

Site Status

Meritus Center for Clinical Resarch

Hagerstown, Maryland, United States

Site Status

Spectrum Clinical Research Inc.

Towson, Maryland, United States

Site Status

Commonwealth Clinical Studies

Brockton, Massachusetts, United States

Site Status

NECCR Internal Medicine and Cardiology Associates LLC

Fall River, Massachusetts, United States

Site Status

ActivMed Practices and Research

Haverhill, Massachusetts, United States

Site Status

University of Michigan Health System

Ann Arbor, Michigan, United States

Site Status

Clinical Research Institute of Michigan, LLC

Chesterfield, Michigan, United States

Site Status

Saginaw Valley Medical Research Group, LLC

Saginaw, Michigan, United States

Site Status

Mayo Clinic

Rochester, Minnesota, United States

Site Status

Gastrointestinal Accociates, PA

Jackson, Mississippi, United States

Site Status

Digestive Research Specialist

Tupelo, Mississippi, United States

Site Status

Midwest Center for Clinical Research

Lees Summit, Missouri, United States

Site Status

Center for Digestive and Liver Diseases, Inc.

Mexico, Missouri, United States

Site Status

St. Louis Center for Clinical Research

St Louis, Missouri, United States

Site Status

Montana Health Research Institute, Inc.

Billings, Montana, United States

Site Status

Dr. Meera Dewan PC

Omaha, Nebraska, United States

Site Status

Anderson & Collins Clinical Research

Edison, New Jersey, United States

Site Status

South Jersey Gastroenterology. P.A.

Marlton, New Jersey, United States

Site Status

Atlantic Research Affiliates

Morristown, New Jersey, United States

Site Status

Life Medi-Research

Brooklyn, New York, United States

Site Status

Long Island Clinical Research Associates, LLP

Great Neck, New York, United States

Site Status

Long Island Gastrointestinal Research Group

Great Neck, New York, United States

Site Status

Winthrop University Hospital Clinical Trials Center

Mineola, New York, United States

Site Status

Research Associates of New York

New York, New York, United States

Site Status

Premier Medical Group of the Hudson Valley

Poughkeepsie, New York, United States

Site Status

Gastrointestinal Research Associates, LLC

Setauket, New York, United States

Site Status

The UNC Center for Functional GI and Motility Disorders

Chapel Hill, North Carolina, United States

Site Status

PMG Research of Charlotte, LLC

Charlotte, North Carolina, United States

Site Status

LeBauer Research Associates, P.A.

Greensboro, North Carolina, United States

Site Status

PMG Research of Hickory, LLC

Hickory, North Carolina, United States

Site Status

Peters Medical Research

High Point, North Carolina, United States

Site Status

Kinston Medical Specialist, P.A.

Kinston, North Carolina, United States

Site Status

Wake Research Associates

Raleigh, North Carolina, United States

Site Status

Trial Management Associates LLC

Wilmington, North Carolina, United States

Site Status

PMG Research of Winston-Salem

Winston-Salem, North Carolina, United States

Site Status

Lillestol Research LLC

Fargo, North Dakota, United States

Site Status

Akron Gastroenterology Associates

Akron, Ohio, United States

Site Status

Gastroenterology Research Consultants of Greater Cincinnati

Cincinnati, Ohio, United States

Site Status

Hometown Urgent Care

Columbus, Ohio, United States

Site Status

Hometown Urgent Care

Dayton, Ohio, United States

Site Status

Hometown Urgent Care and Research

Groveport, Ohio, United States

Site Status

Hometown Urgent Care and Research

Miamisburg, Ohio, United States

Site Status

Physicians Research, Inc

Zanesville, Ohio, United States

Site Status

Journey Clinical Research

Duncan, Oklahoma, United States

Site Status

Central Sooner Research

Norman, Oklahoma, United States

Site Status

Oklahoma Foundation for Digestive Research

Oklahoma City, Oklahoma, United States

Site Status

Lynn Health Science Institute

Oklahoma City, Oklahoma, United States

Site Status

Sooner Clinical Research

Oklahoma City, Oklahoma, United States

Site Status

Northwest Gastroenterology Clinic, LLC

Portland, Oregon, United States

Site Status

Safe Harbor Clinical Research

East Providence, Rhode Island, United States

Site Status

Southeast Medical Research

Charleston, South Carolina, United States

Site Status

SC Clinical Research, LLC

Columbia, South Carolina, United States

Site Status

Coastal Carolina Research Center in Goose Creek

Goose Creek, South Carolina, United States

Site Status

Hillcrest Clinical Research, LLC

Simpsonville, South Carolina, United States

Site Status

Midwest Medical Care

Sioux Falls, South Dakota, United States

Site Status

Gastroenterology Associates

Bristol, Tennessee, United States

Site Status

ClinSearch, LLC

Chattanooga, Tennessee, United States

Site Status

Alpha Clinical Research

Clarksville, Tennessee, United States

Site Status

Memphis Gastroenterology Group

Germantown, Tennessee, United States

Site Status

Associates in Gastroenterology

Hermitage, Tennessee, United States

Site Status

Gastroenterology Associates Clinical Research

Kingsport, Tennessee, United States

Site Status

Columbia Medical Group -The First Clinic, Inc.

Nashville, Tennessee, United States

Site Status

Dial Research Associates, INC

Nashville, Tennessee, United States

Site Status

TN Medical Research

Spring Hill, Tennessee, United States

Site Status

Research Across America/ Family Medicine Associates of Texas

Carrollton, Texas, United States

Site Status

Corsicana Medical Research, PLLC

Corsicana, Texas, United States

Site Status

Texas University Health Sciences Center

El Paso, Texas, United States

Site Status

Gastroenterology Consultants, P.A.

Houston, Texas, United States

Site Status

Houston S. Endoscopy and Research Center

Houston, Texas, United States

Site Status

Pioneer Research Solutions, Inc

Houston, Texas, United States

Site Status

Digestive Health Associates of Texas

Plano, Texas, United States

Site Status

Sun Research Institute

San Antonio, Texas, United States

Site Status

Clinical Trials of Texas

San Antonio, Texas, United States

Site Status

Advanced Research Institute

Clinton, Utah, United States

Site Status

Advanced Research Institute

Logan, Utah, United States

Site Status

Advanced Research Institute

Ogden, Utah, United States

Site Status

Advanced Research Institute

Sandy City, Utah, United States

Site Status

Gastroenterology, Ltd.

Virginia Beach, Virginia, United States

Site Status

Wisconsin Center for Advanced Research

Milwaukee, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ASMP3001

Identifier Type: -

Identifier Source: org_study_id